Perrigo Foresees 2008 Omeprazole Launch; New Products Offset Sales Woes
This article was originally published in The Tan Sheet
Executive Summary
Perrigo expects to be able to launch the first store-brand equivalent to Prilosec OTC in November 2008, at the expiration of a 30-month stay
You may also be interested in...
Perrigo Hopes To Retain Lead From Leiner Woes, Eyes Private Label Zyrtec
Prompted by the sudden voluntary suspension of Leiner Health Product's U.S. OTC operations, private labeler Perrigo is looking to maintain its increased market share via key adjustments in its production processes to meet high customer demand
Perrigo Head Tightens Reins On Consumer Healthcare Sales, Marketing
Perrigo has moved its Consumer Healthcare head to direct global operations for OTC and Rx products while President and CEO Joseph Papa will have the firm's consumer products sales and marketing staff report directly to him
OTC omeprazole
Synovics Pharmaceuticals announces March 15 it has entered into a binding letter of intent for exclusive, worldwide rights to the development and commercialization of an OTC omeprazole. Contract processor Fluid Air will deliver the product to Phoenix-based Synovics' subsidiary Kirk Pharmaceuticals. Fluid Air's DuraGran technology will allow Synovics to avoid patent infringement, the firm says. Synovics, formerly known as Bionutrics, bought Kirk in July 2005 (1"The Tan Sheet," Aug. 1, 2005, In Brief). Synovics plans to submit an ANDA in the second half of 2007. Perrigo said in a February analyst call it expects to launch an omeprazole product in November 2008 (2"The Tan Sheet," Feb. 5, 2007, p. 5). Under a licensing agreement, Schering-Plough hopes to bring Santarus' immediate release omeprazole product Zegerid to the market as well (3"The Tan Sheet" Nov. 27, 2006, In Brief)...